|

Denosumab 120 MG/1.7 ML Subcutaneous Solution [XGEVA] Clinical Trials

1 actively recruiting trial across 1 location

Top Sponsors

  • University of Colorado, Denver1

Indications

  • Carcinoma, Non-Small-Cell Lung1
  • Lung Cancer1
  • Cancer1

Aurora, Colorado1 trial

Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers With Actionable Driver Mutations.

University of Colorado Hospital

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.